Nelson Labs of Sotera Health Announces Acquisition of Gibraltar Laboratories of New Jersey
Thursday, August 09, 2018
Sotera Health, the world's leading, fully integrated global health solutions provider, has acquired Gibraltar Laboratories of New Jersey. The acquisition expands the analytical testing capabilities of Nelson Labs' Sotera Health US business. Gibraltar Laboratories is a leading outsourced provider of tests in microbiology and analytical chemistry for pharmaceutical and medical device manufacturers. Silence has been agreed on the terms of the transaction.
Headquartered in Fairfield, New Jersey, Gibraltar Laboratories has an excellent reputation for customer service, technical expertise and quality performance. Gibraltar is known for USP-compliant tests in the fields of microbiology, sterility assurance and analytical chemistry. The company, owned and operated by the Prince family since 1970, maintains two laboratories in the three-state territory of New Jersey.
"Gibraltar Laboratories is a respected laboratory known for its strong customer relationships with US pharmaceutical manufacturers," said Michael B. Petras Jr., CEO of Sotera Health. "In addition to its testing expertise, Gibraltar maintains its facilities in the Northeastern Pharmaceutical Corridor, which is home to many of the United States leading pharmaceutical manufacturers. With the acquisition, we are expanding our presence in this important region and further strengthening our testing capacity for the pharmaceutical industry. We are pleased that the strong leaders and professionals of Gibraltar are joining our mission, Safeguarding Global Health TM . "
"With the involvement of three generations of the Prince family and our experienced microbiology and chemistry professionals, we have made a name for ourselves as a trusted, flexible and highly professional partner for our clients, and we know that this is true for Sotera Health," he said Dr. Daniel L. Prince, President of Gibraltar Laboratories. "My goal is for Gibraltar to build on its many years of excellent reputation and to further expand its offerings. We achieve this through our future affiliation with Sotera Health, a global player whose breadth of capabilities and breadth and depth are of tremendous value to the industries we proudly serve. "
"The offerings and strategic location of Gibraltar's facilities will be a great asset to our mutual customers, who value working with a trusted partner who can deliver quality, service and expertise," said Nelson Labs President Jeff Nelson. "The Gibraltar team is known for these values, and has an excellent reputation for developing specialist studies that help manufacturers demonstrate the safety, efficacy and legal compliance of their products. Moreover, I find it extremely exciting to work directly with Dr. med. Daniel Prince, who is one of the masterminds of our field. "
Gibraltar will complement Nelson Labs' Sotera Health business. Gibraltar's expertise in pharmaceutical products and analytical testing capabilities will extend Nelson Labs' existing strengths in medical technology and microbiology consulting services. Gibraltar's facilities are registered with the FDA, certified to ISO 17025 and are accredited to be accredited for both the microbiological and chemical sectors. The acquisition of Gibraltar Laboratories does not include Prince Sterilization Services, LLC. However, both companies are pleased that Gibraltar continues to partner with Prince Sterilization Services,
About Sotera Health : Together with its business units, Sotera Health LLC is the world's leading, fully integrated provider of global health protection solutions. With over 500 years of combined scientific expertise, the company provides healthcare security by providing mission critical services to the medical, pharmaceutical, tissue and food industries. Sotera Health operates 63 plants in 13 countries. The company employs more than 2,600 people worldwide and reaches more than 180 million people worldwide each year. Sotera Health serves more than 5,000 customers worldwide, including 75 of the top 100 medical device manufacturers.
Sotera Health is Nelson Labs ™ , Nordion® and Sterigenics® with its three best-in-class companies Representing the safety of health care on a daily basis with the goal of being on the market. Nelson Labs offers microbiological and analytical testing and expert advice to help customers develop and maintain sterilization solutions for medical, tissue and implantable devices, as well as the pharmaceutical and biological industries. Nordion is the world's largest supplier of Cobalt-60, which is used in the gamma sterilization process. Sterigenics offers on-demand comprehensive sterilization and ionization solutions for the medical, pharmaceutical, food safety and high performance materials industries.
Sotera Health LLC is owned by private equity firms Warburg Pincus and GTCR. For more information about Sotera Health , visit soterahealth.com , Nelson Labs at nelsonlabs.com , Nordion at nordion.com, and Sterigenics at sterigenics.com .
About Nelson Laboratories : Nelson Laboratories, LLC is the industry leader in global laboratory testing and consulting services. Nelson Labs has over 400 rigorous microbiological and analytical laboratory tests, including a best-in-class test platform for extractables and leachables, for the medical, pharmaceutical and tissue industries. The company is considered a best-in-class partner, and is extremely successful in working with customers to solve complex problems. With 11 global lab locations in eight countries, Nelson Labs is committed to protecting the health of every single test conducted under the banner of Safeguarding Global Health TM .
About Gibraltar Laboratories: Gibraltar Laboratories has set the gold standard for contract laboratories with an excellent reputation for customer service, quality research, quality control and testing in the fields of stem cells, bacteriology, mycology, virology, chemistry, purification validation and in vitro toxicology. Gibraltar Laboratories is a competent partner for the pharmaceutical, medical technology, orthopedic, biopharmaceutical, chemical and cosmetics industries as well as tissue banks. The company operates two laboratories and is headquartered in Fairfield, New Jersey. For more information, visit www.gibraltarlabsinc.com .
The source language in which the original text is published is the official and authorized version. Translations will be included for a better understanding. Only the language version published in the original is legal. Compare translations with the original language version of the publication.
Contacts
Dix & Eaton for SOTERA HEALTH:
Angela Martin, 216-241-2148
amartin@dix-eaton.com
or
GIBRALTAR LABORATORIES:
Danina Rinaldi, 973-227-6882, ext. 529
Technical Services Manager
drinaldi@gibraltarlabsinc.com